Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Heise

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 14, 2005
Synthesis and structure-activity relationships of biarylcarboxamide bis-aminopyrrolidine urea derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1)Martin W Rowbottom, Troy D Vickers, Brian Dyck, et al.
Bioorganic & Medicinal Chemistry Letters|March 14, 2007
Synthesis and structure-activity relationships of spirohydantoin-derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1)Martin W Rowbottom, Troy D Vickers, Junko Tamiya, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2006
Synthesis and structure-activity relationships of retro bis-aminopyrrolidine urea (rAPU) derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1). Part 2Sarah Hudson, Mehrak Kiankarimi, Martin W Rowbottom, et al.
Bioorganic & Medicinal Chemistry Letters|July 4, 2006
Synthesis and structure-activity relationships of retro bis-aminopyrrolidine urea (rAPU) derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1). Part 1Martin W Rowbottom, Troy D Vickers, Brian Dyck, et al.
Journal of Medicinal Chemistry|June 23, 2006
A thienopyridazinone-based melanin-concentrating hormone receptor 1 antagonist with potent in vivo anorectic propertiesBrian Dyck, Stacy Markison, Liren Zhao, et al.
Journal of Medicinal Chemistry|June 2, 2015
Structure-Guided Design of Group I Selective p21-Activated Kinase InhibitorsJames J Crawford, Wendy Lee, Ignacio Aliagas, et al.
The Journal of Biological Chemistry|July 31, 2013
Histone deacetylase (HDAC) inhibitor kinetic rate constants correlate with cellular histone acetylation but not transcription and cell viabilityBenjamin E L Lauffer, Robert Mintzer, Rina Fong, et al.
ACS Medicinal Chemistry Letters|November 17, 2023
Lipid Tales: Optimizing Arylomycin Membrane AnchorsMichael F T Koehler, Yi-Chen Chen, Yongsheng Chen, et al.
Science Translational Medicine|May 27, 2011
A therapeutic antibody targeting BACE1 inhibits amyloid-β production in vivoJasvinder K Atwal, Yongmei Chen, Cecilia Chiu, et al.
Plos One|December 11, 2012
Mechanistic and structural understanding of uncompetitive inhibitors of caspase-6Christopher E Heise, Jeremy Murray, Katherine E Augustyn, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry Letters|June 14, 2005
Synthesis and structure-activity relationships of biarylcarboxamide bis-aminopyrrolidine urea derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1)Martin W Rowbottom, Troy D Vickers, Brian Dyck, et al.
Bioorganic & Medicinal Chemistry Letters|March 14, 2007
Synthesis and structure-activity relationships of spirohydantoin-derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1)Martin W Rowbottom, Troy D Vickers, Junko Tamiya, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2006
Synthesis and structure-activity relationships of retro bis-aminopyrrolidine urea (rAPU) derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1). Part 2Sarah Hudson, Mehrak Kiankarimi, Martin W Rowbottom, et al.
Bioorganic & Medicinal Chemistry Letters|July 4, 2006
Synthesis and structure-activity relationships of retro bis-aminopyrrolidine urea (rAPU) derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1). Part 1Martin W Rowbottom, Troy D Vickers, Brian Dyck, et al.
Journal of Medicinal Chemistry|June 23, 2006
A thienopyridazinone-based melanin-concentrating hormone receptor 1 antagonist with potent in vivo anorectic propertiesBrian Dyck, Stacy Markison, Liren Zhao, et al.
Journal of Medicinal Chemistry|June 2, 2015
Structure-Guided Design of Group I Selective p21-Activated Kinase InhibitorsJames J Crawford, Wendy Lee, Ignacio Aliagas, et al.
The Journal of Biological Chemistry|July 31, 2013
Histone deacetylase (HDAC) inhibitor kinetic rate constants correlate with cellular histone acetylation but not transcription and cell viabilityBenjamin E L Lauffer, Robert Mintzer, Rina Fong, et al.
ACS Medicinal Chemistry Letters|November 17, 2023
Lipid Tales: Optimizing Arylomycin Membrane AnchorsMichael F T Koehler, Yi-Chen Chen, Yongsheng Chen, et al.
Science Translational Medicine|May 27, 2011
A therapeutic antibody targeting BACE1 inhibits amyloid-β production in vivoJasvinder K Atwal, Yongmei Chen, Cecilia Chiu, et al.
Plos One|December 11, 2012
Mechanistic and structural understanding of uncompetitive inhibitors of caspase-6Christopher E Heise, Jeremy Murray, Katherine E Augustyn, et al.
Pageof 8